Abstract
Background
In allergology practice, efficient counselling of cat owners is often frustrating because the topic of allergen avoidance is mostly a “no-go” and there are only few studies on allergen immunotherapy that prove its efficacy. In the end, what patients are mostly offered in allergy consultations are allergen reduction measures and symptomatic therapy.
Results
Sensitisation to the main cat allergen Fel d 1 occurs more frequently in atopic conditions and then represents a risk for allergic rhinitis and asthma. Current guidelines are therefore cautious about the first-time acquisition of a cat in the first months of life in atopic families. However, sensitisation occurs in many cases even without contact with an own cat at home.
Conversely, it has been observed in adult patients that in the case of high Fel d 1 exposure immunological tolerance can also develop through the induction of specific IgG4. The fact that many cat allergic patients keep their animals despite diagnosis is, however, partly due to the psychological phenomenon of coping.
Conclusion
In this review, we present current literature and facts that should make everyday life easier for patients, even without giving up the animal. We also review best practices in the management of cat allergy and present new management options and concepts from the development pipeline that our patients are eagerly awaiting.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Pets are kept in about one in three households in Germany, including 29% in single-person households, 35% in households with 2 persons, 36% in households with 3 or more persons, but in 67% of households with children [1]. The figures in Austria are very similar [2], but Austrian pets are well distributed between single households and families with children (retrieved from www.statista.com, April 2023). During the coronavirus pandemic, the number of pets increased by about 5%. In Germany, this meant an increase of 1 million pets alone in 2020—the pet supplies segment was thus a big winner of the pandemic [3].
Which animals usually are kept in households is country-specific and probably culture-dependent. Cats as pets are popular in Germany (29%) and Austria (24%), surpassed by e.g. France (41%), Belgium (33%) and Russia (57%). About twice as many women than men tend to keep cats rather than dogs [4]. An impressive number of 15.2 million cats lived in Germany, and 2 million cats in Austria, according to a standardised survey by a market research institute in the survey period 2021 [4]. In contrast, however, dogs take a top position among pets in the international comparison with an average of 33% (up to 66% in Argentina) [5]. Registration of the animals is not obligatory, so a veritable number of unreported cases can be assumed.
Pet owners in the allergology practice
Pets arguably provide carefree quality time in otherwise uncertain times, give a sense of stability and support social interaction. Moreover, there are actually proven health benefits: in a systematic review and meta-analysis of 26 studies, there was a decrease in cardiovascular mortality specifically among cat but not dog owners [6]. Pets are seen as a friend, and increasingly as a family member. This is also evident from the fact that, following a trend from the USA, pet owners are in Europe also mutating from “master and mistress” to parents (“mum and dad”) and are also addressed as such by the treating veterinarian. This new phenomenon is also termed “pet parenting” [7]. In fact, did you know that there is a worldwide international “Hug Your Cat Day” on 4th of June? Thus, counselling pet owners requires special empathy in allergy consultations, because allergen avoidance is not enforceable in the vast majority of cases.
In German-speaking countries, according to statistics, among animal allergy sufferers we deal most with cat owners in the allergy consultation, about half of them being women. They consult the allergist because of allergic rhinitis and conjunctivitis, some for urticarial lesions after contact with saliva or claws, or for asthmatic complaints. Cat allergen can also be distributed via urine, but in much smaller quantities [8]. Cat allergy sufferers often report an itchy palate after high exposure to allergens [9].
In general, the numbers of sensitisations to cat among all animal sensitisations are increasing, as reported in various international studies. In the Swedish OLIN study (n = 1657), the prevalence of sensitisation (SPT) to cats increased from 19.1% to 26.6% between ages 7–8 to 11–12 years [10]. In the Swedish BAMSE birth cohort (n = 4000, between 4 and 24 years), sensitisation to cats reached 19.6% [11]. The trend is also strongly increasing in Germany [12]: In 13,000 children aged 3–17 years, the prevalence of sensitisation to animals in general climbed from 5.7% in 3–6 year olds to 17.2% in 14–17 year olds. While the course is thus set in childhood, a plateau is probably reached from adolescence onwards, as reported by a Finnish study [13]. Also for adults, cat ownership means a significant risk for subsequent sensitisation [14]. In turn, existing sensitisation is seen in many studies as an increased risk for asthma [15].
What speaks against or for cat ownership
In a meta-analysis of 34 adult cohorts, cat ownership protected against, or at least did neither favour the development of allergic rhinitis nor of asthma [16]. Thus, based on epidemiological studies, keeping cats during and after the first year of life has even been suggested as a strategy against sensitisation [17]. The necessary allergen amounts, time periods, genotype and necessary cofactors have not yet been systematically investigated. Therefore, there are no convincing recommendations for the primary prevention of cat allergy, but secondary prevention in preschool age seems to protect against deterioration of lung function up to asthma [18]. Here, counselling often fails because of the love for the animals.
Patients sensitized to cat who claim that their own cat is tolerated, while others elicit symptoms, are regularly seen in allergology consultations. In most cases, the nasal language and other allergic phenotypes speak more for psychological coping with the unavoidable situation. However, some cat owners despite manifest allergy seem to have actually reached a stage of tolerance during living with the cat. IgG4 immunoglobulins have been discussed for years as a mechanism of tolerance in cat allergy. These are formed during chronic and high antigen exposure and could thus transform an initially unfavourable Th2 immune response into a protective Th2 response [19]. In a study comparing feline asthmatics with or without a cat at home, higher specific IgE levels were detectable when living with the cat; at the same time, higher thresholds for basophil reactivity to allergen were found in the cohort with a cat at home, and this correlated with the presence of Fel d 1-specific IgG4 [20]. Based on the principle that specific IgG4 could positively influence clinical reactivity against cats, new immunotherapeutics are now being considered.
Although only about half as many households have cats in Turkey compared to households in German-speaking countries, a number of recent studies have been carried out there. For example, the prevalence of cat sensitisation was 6% in a cohort of 3033 patients who visited an allergy clinic because of hypersensitivity to cats. These patients suffered more frequently from allergic rhinitis associated with cat contact (29.4%) than from asthma or combined symptoms, while 28% of those sensitised had no symptoms [21].
A larger number (17.3%) of the diagnosed cat allergy sufferers had a cat at home, while 13.4% of patients had contact with a cat but no cat of their own. In another Turkish study, cat sensitisation was evaluated with skin prick tests. Of those who tested positive, 33.9% were cat owners themselves, all of whom preferred to live with the animals, although two-thirds of them actually had rhinitis symptoms [22].
Because more animals, including a disproportionate number of cats, were newly acquired during the coronavirus pandemic, the rate of patients presenting as sensitised to cats in/after the pandemic (15%) increased significantly compared to prepandemic rates (4.4%) [23].
But who gets sensitised against cats?
Allergen levels are naturally higher in households with cats, with the major allergen Fel d 1 being the most significant biomarker not only for sensitisation (IgE, positive skin prick test, no symptoms) but for the risk of clinically relevant cat allergy and cat asthma. In monosensitisation, Fel d 1 is the only IgE biomarker [24] and can be found in both air and beds [25] (and in the cat litter box [8]). In several birth cohorts, there was a linear dose–response relationship between the amount of allergen in the environment and the risk of sensitisation [26]. The risk particularly affected infants up to 1 year of age. Thereafter, the rate of sensitisation among children in cat families increased by 6% per year less than in families without cats. The prevalence of cat sensitisation was then the same in both groups in adolescence.
Particular advice should be given to families with a parental atopic predisposition of one or both parents, which is transmitted to 30–60% of their children. This also explains why individuals with the same allergen exposure, e.g. in a shared living space, do not all become sensitised. Under the term “gene–environment interaction”, in earliest childhood the specific FLG genotype (fillagrin mutations) together with Fel d 1 exposure determines the course of, either cat sensitisation, or whether protection can be built up against it [27]. The situation is more complex with regard to asthma. Here, genetic variations of the ORMDL3 gene on chromosome 17q21 have been correlated with asthma. The genotypes rs7216389 [28] and rs2305480 [29] are high-risk markers associated with Fel d 1 exposure.
The current German guidelines on allergy prevention [30] advise that, in the case of atopic predisposition and a desire for animals, a cat should be acquired later rather than in the critical first months of life.
However, the last word may not yet be spoken. This is announced by some recent studies which show that, depending on the timing of exposure, also protection could be provided: The Copenhagen Prospective Studies on Asthma in Childhood2000 study [28], which investigated animal exposure to cats and dogs, found that high levels of exposure to cat allergens prevented the development of asthma until 12 years of age. The Danish National Birth Cohort Study summarises that cat exposure in early childhood has no, or rather a mild protective effect against atopic eczema, asthma and allergic rhinitis [31].
Cat exposure in pregnancy and early childhood has also recently been associated with a protective effect against food allergies (specifically eggs, wheat and soy) in The Japan Environment and Children’s Study [32].
Management of cat allergy: how do I tell the patient?
Tertiary prevention: allergen avoidance with existing sensitisation?
In the delicate diagnostic exploration of cat allergy sufferers, in which the cat is respectfully addressed as a family member, the consequences of continued chronic exposure on a progression of the disease towards respiratory complaints up to asthma should be explained, especially for cat owners with atopic risk.
An essential part of the conversation is to inform the patient that a large proportion of cat allergy sufferers do not need to own a cat themselves in order to suffer from symptoms. Patients should be informed about the high persistence of Fel d 1 allergens on textiles, furniture and generally in homes that have been inhabited by cats. The possibility of indirect exposure via schoolmates or colleagues should also be explained. Likewise, advice should be given on the treatment of bedrooms, textile hygiene, the use of air filtration devices, including all bedrooms, in order to provide respite from allergen exposure at least at night. Keeping animals in all bedrooms should be avoided in affected families. To this end, it should be understood that children’s rooms are also bedrooms. It will usually not be possible to also get other rooms cat-free.
In general, the type and amount of exposure to cats has changed. While in the countryside cats still tend to stay outdoors and rarely come into living spaces, in the context of urbanisation we observe the phenomenon of the indoor cat, which is kept hygienically impeccable and, from an allergological point of view, in rooms that are too clean. Therefore, indoor cats are usually a source of much higher allergen load, with a simultaneous lack of dirt exposure, which, according to the hygiene hypothesis, would be better counter-regulated by a stray cat.
Therefore, alternative measures for allergen reduction are called for. These include washing with detergents and mechanical cleaning, especially in combination with tumble dryers [33]. This includes the treatment of all home textiles, including textiles directly contaminated by the cat. Air filtration devices are helpful against indoor cat asthma if they are equipped with HEPA (high-efficiency particulate air) filters [34]. This was also confirmed in a study in an allergen exposure chamber, where relief against immediate type as well as late phase reactions were recorded when air filters were applied [35].
The race to create a hypoallergenic cat that secretes less or no Fel d 1, however, is still undecided [36]. Naked cats or the more sparsely haired werewolf cats, distinguished by hypotrichia [37], still secrete their Fel d 1 via saliva, while possibly the distribution of the allergen via dander might be reduced.
Perhaps the most original approach is to immunise cats against Fel d 1 coupled to virus-like particles to reduce allergen excretion. Clinical studies have shown that by inducing neutralising anti-Fel d 1 autoantibodies in the cat, a significant reduction in symptoms could be achieved in cat owners [38]. This allowed them to devote more time to petting their Fel d 1-vaccinated animals without falling into a sneezing attack.
Symptomatic therapy
Prescriptions for antihistamines or mast cell stabilizers, including cromoglicic acid (nasal spray, eye drops) should be issued in any case; an asthma spray (inhaled betamimetic, for example formoterol, plus corticosteroid) is also recommended in case of wheezing. Advise your cat allergy sufferers to take symptomatic treatment before visiting cat owners if the visits cannot be avoided. For contact urticaria, topical H1 receptor blockers may be useful in addition to antigen abstinence. If respiratory symptoms are present, pulmonary function should be checked and drug therapy should be coordinated with the pulmonologist.
The whole family should be informed about the risk of an allergic reaction and, if necessary, medicines and asthma sprays should be deposited, e.g. with the grandparents who own a cat.
Specific allergen immunotherapy
Is a 3-year course of allergen immunotherapy (AIT) an option for cat allergy sufferers? Some patients specifically request it, but an analysis of systematic reviews by the European Association of Allergy and Clinical Immunology did not result in a clear recommendation [39]. Admittedly, there are hardly any major studies on cat AIT. This may be partly due to the industry’s tasks in terms of the therapy allergen ordinance regarding AIT studies for the more common allergens (pollen, mites). Further developments for AIT in animal (hair) allergies, improvements in terms of standardisation and increased safety are currently on hold. A Spanish–Swedish study team reported on the safety of a new feline subcutaneous immunotherapy (SCIT) procedure using rapid updosing by infusion pump, but systemic reactions occurred in 8.1% of the doses administered; during the maintenance phase without a pump, there were still 9.3% systemic reactions [40]. Nevertheless, improvements in allergic symptoms, medication consumption, the asthma control test and quality of life were substantial in cat allergy [40], and lasted at least 6 months.
Other studies have also described a relatively high risk of systemic allergic reactions, particularly with anti-cat SCIT [41].
Sublingual immunotherapy (SLIT) is an option for cat allergy with good results in some cases, as shown in double-blind placebo-controlled trials [42], but there have been no new developments [39].
One may therefore think about improvements. Allergoids are commonly used in Europe to increase the safety of allergens for AIT. Glutaraldehyde and other chemical processes link allergen molecules to larger complexes that can no longer cross-link IgE. This has also been achieved for Fel d 1 and a corresponding allergoid was practically applied [43]. An alternative option would be to make the cat allergen more immunogenic. While most SCIT administrations use aluminium hydroxide as an adjuvant, cytosine–phosphorothioate–guanine oligodeoxynucleotides (CpG-oligonucleotides) could promote a Th1 response counteracting the allergy, associated with the generation of Foxp3hi Treg cells as well as an anti-inflammatory TNF/TNFR2 signalling cascade [44]. This possibility has been supported in animal models [45].
Disappointingly, a change in application to the intralymphatic route (ILAIT) failed to produce therapeutic improvement in cat allergy [46].
In the pipeline: biologics against Fel d 1
Having arrived in the era of biologics, a number of compounds are available for use in severe allergic asthma and rhinitis that have allergen-nonspecific mechanisms of action by targeting IgE or downregulating cytokines. This differs from a new allergen-specific approach using anti-Fel d 1 IgG4 immunoglobulins. On the one hand, the IgG4 blocks the allergen and thereby prevents symptoms. On the other hand, it exploits a mechanism typical for the IgG4 subclass: IgG4 has a better anti-inflammatory effect than other IgG subclasses via FcgRIIb receptors on macrophages and other inflammatory cells [47]. REGN1908-1909 is a cocktail of two monoclonal IgG4 anti-Fel d 1 IgG4 antibodies, which after subcutaneous application not only leads to a lower reaction in the skin prick test [48], but in a double-blind placebo-controlled study prevented both the symptoms of allergic rhinitis [49] and allergic asthma after cat exposure in a standardised exposure chamber [50].
New: dietary management of cat allergy
A special risk for specific sensitisation, including against cats, exists in atopy. But what is the actual cause of atopy? In addition to a genetic predisposition, including the risk alleles described above, environmental factors are increasingly being considered that affect the epigenome, i.e. cause chemical changes in histone proteins and DNA [51]. This can be countered by so-called “green spaces”, which contribute to a richness of the (intestinal) microbiota [52].
A recent finding is that nutritional deficiencies support the atopic phenotype [53]. Of particular note among these are iron and zinc deficiency, but also folic acid deficiency. Anaemia has been significantly linked to the risk of developing atopy and subsequent allergic symptoms in international studies [54,55,56]. Often it is not a matter of classic anaemia characterized by lower erythrocyte counts, haemoglobin associated with impaired iron parameters in the laboratory test results, but of a so-called “functional iron deficiency”, which particularly affects immune cells [57]. Functional iron deficiency is much more difficult to detect in the laboratory, as confirmed by current guidelines [58]. This is not an absolute iron deficiency, but rather an iron utilisation disorder. In the deficiency situation, immune cells tend to retain iron and release less iron. Thus in situations when the so-called “labile iron pool” in macrophages and other regulatory cells is reduced, they cannot fulfil their immunomodulatory role and become pro-inflammatory. In a setting of iron deficiency, the pro-allergic Th2 cells also survive longer than Th1 cells and drive the immune response further towards allergy.
We have found in our own work that functional iron deficiency is a problem in allergic rhinitis, and that it is also associated with a deficiency of iron-producing microbes [59].
The fact that, conversely, allergy can also lead to anaemia [60] reinforces the close causal relationship between a balanced iron balance and the capacity of immune cells to have an immunomodulatory effect.
We concentrated on specifically compensating for this intracellular iron deficiency and thus correcting the natural regulatory function of immune cells [61]. Building on this finding in combination with the well-known farm effect against allergies [62], our own work has led to the development of a holo beta-lactoglobulin (holoBLG) lozenge that showed efficacy as a dietary compound in a double-blind placebo-controlled study in pollen allergy, as well as in an European Centre for Allergy Research Foundation (ECARF) provocation chamber study in house dust mite rhinitis [63]. The clinical efficacy of this dietary approach therefore also produced highly significant clinical improvements.
Since these studies proved the allergen-nonspecific mechanism of the holoBLG lozenge, it was obvious to pursue the question whether an application in cat allergy would be useful.
Therefore, we recently conducted a study in the ECARF exposure chamber on 35 patients with allergic rhinitis to cat allergens. The results of this open-label pilot study showed that 40% improvement in the symptoms specifically associated with allergen provocation could be achieved after only 3 months of supplementation [9]: Allergic ocular symptoms decreased by 33%, the total nasal symptom score (TNSS) decreased by 50%, and itching in general decreased by 50%. In nasal provocation, peak inspiratory nasal flow (PNIF) was improved in the holoBLG-treated patients, and remained negative in 12 of those tested even at the highest allergen dose in the provocation, while 8 reacted only at a higher allergen dose.
Thus, this provocation chamber study indicates that dietary measures can also correct clinically manifest cat allergy. Considering the abundance of nonqualified “food supplements”, it seems appropriate to clearly distinguish and emphasise the scientifically sophisticated “dietary management” by means of targeted micronutrition with holoBLG. An overview of the different treatment options for cat allergy is given in Fig. 1.
Synopsis
Allergy to cats particularly affects people with atopic predisposition, and the most significant biomarker is IgE against Fel d 1. Current guidelines advise against acquiring a cat for the first time in early childhood, especially in atopic families. It is unclear how non-cat owners develop clinically significant sensitisation and why some cat owners develop tolerance (often only to their own animal). Although immunological mechanisms are clear and are thought to run via IgG4 induction after high allergen exposure, psychological mechanisms also play a role in coping with cat allergy. However, negation of the allergic disease carries the risk of progression to chronic disease and asthma. Therefore, medical counselling of cat allergy sufferers is particularly delicate. Conversely, the repertoire in the allergological toolbox is limited, resulting mostly in physical allergen reduction recommendations combined with symptomatic treatment. This is due to the fact that the evidence base on the efficacy of allergen immunotherapy is limited and larger studies are needed. For the management of cat allergy, there is therefore currently a high demand for alternative but evidence-based strategies. These include active and passive immunological and micronutritional approaches in the cat or in cat-allergic humans.
References
Industrieverband Heimtierbedarf e. V. IVH. Der Deutsche Heimtiermarkt. 2022. https://www.ivh-online.de/der-verband/daten-fakten/der-deutsche-heimtiermarkt.html.
Neuteufel N. In jedem zweiten Haushalt in Österreich lebt ein Tier. MeinBezirk 2. Oktober 2022. https://www.meinbezirk.at/c-lokales/in-jedem-zweiten-haushalt-in-oesterreich-lebt-ein-tier_a5617351; accessed on March 1, 2023
dpa. Eine Million mehr Haustiere in der Pandemie. Zeit online 22. März 2021. https://www.zeit.de/news/2021-03/22/eine-million-mehrhaustiere-in-der-pandemie?utm_referrer=https%3A%2F%2Fwww.google.com%2F; accessed on 6.6.2023
Statista-Research-Department. Anzahl der Haustiere in Österreich. 2023. http://www.statista.com. Accessed 27 Sept 2022.
Growth-from-Knowledge. Haustiere im internationalen Vergleich. https://www.gfk.com/de/insights/haustiere-im-internationalen-vergleich. Accessed 24. Mai 2016
El-Qushayri AE, Kamel AMA, Faraj HA, Vuong NL, Diab OM, Istanbuly S, et al. Association between pet ownership and cardiovascular risks and mortality: a systematic review and meta-analysis. J Cardiovasc Med. 2020;21(5):359–67.
Volsche S. Pet parenting in the United States: investigating an evolutionary puzzle. Evol Psychol. 2021;19(3):14747049211038297.
Kelly SM, Karsh J, Marcelo J, Boeckh D, Stepner N, Santone B, et al. Fel d 1 and Fel d 4 levels in cat fur, saliva, and urine. J Allergy Clin Immunol. 2018;142(6):1990–1992e3.
Bergmann KC, Raab J, Graessel A, Zwingers T, Becker S, Kugler S, et al. The holoBLG lozenge reduces symptoms in cat allergy—evaluation in an allergen exposure chamber and by titrated nasal allergen challenge. Clin Transl Allergy. 2023;. in press.
Bunne J, Moberg H, Hedman L, Andersson M, Bjerg A, Lundback B, et al. Increase in allergic sensitization in schoolchildren: two cohorts compared 10 years apart. J Allergy Clin Immunol Pract. 2017;5(2):457–463e1.
van Hage M, Kack U, Asarnoj A, Konradsen JR. An update on the prevalence and diagnosis of cat and dog allergy—Emphasizing the role of molecular allergy diagnostics. Mol Immunol. 2023;157:1–7.
Schmitz R, Ellert U, Kalcklosch M, Dahm S, Thamm M. Patterns of sensitization to inhalant and food allergens—findings from the German health interview and examination survey for children and adolescents. Int Arch Allergy Immunol. 2013;162(3):263–70.
Haarala AK, Sinikumpu SP, Vaaramo E, Jokelainen J, Timonen M, Auvinen J, et al. Incidence and remission of aeroallergen sensitization in adults in Northern Finland: 15 years longitudinal study. Sci Rep. 2021;11(1):4249.
Won JY, Kwon JW, Hong SN, Lee WH. Age differences in pet sensitization by pet ownership. Clin Exp Otorhinolaryngol. 2021;14(2):210–6.
Simoneti CS, Ferraz E, Menezes MB, Icuma TR, Vianna EO. Cat ownership is associated with increased asthma prevalence and dog ownership with decreased spirometry values. Braz J Med Biol Res. 2018;51(12):e7558.
Gao X, Yin M, Yang P, Li X, Di L, Wang W, et al. Effect of exposure to cats and dogs on the risk of asthma and allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2020;34(5):703–14.
Al-Tamprouri C, Malin B, Bill H, Lennart B, Anna S. Cat and dog ownership during/after the first year of life and risk for sensitization and reported allergy symptoms at age 13. Immun Inflamm Dis. 2019;7(4):250–7.
Roberts G, Fontanella S, Selby A, Howard R, Filippi S, Hedlin G, et al. Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma. J Allergy Clin Immunol. 2020;146(4):821–30.
Renand A, Archila LD, McGinty J, Wambre E, Robinson D, Hales BJ, et al. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization. J Allergy Clin Immunol. 2015;136(6):1627–1635e13.
Wambre ER, Farrington M, Bajzik V, DeBerg HA, Ruddy M, DeVeaux M, et al. Clinical and immunological evaluation of cat-allergic asthmatics living with or without a cat. Clin Exp Allergy. 2021;51(12):1624–33.
Severcan EU, Baskaya N, Ertugrul A, Emeksiz ZS, Bostanci I. Characteristics of children with cat sensitivity: a prospective cross-sectional study. Turk J Med Sci. 2023;53(1):360–5.
Gultuna S. Clinical characteristics of cat sensitized adults, cat ownership and cat owners’ attitudes. Allergy Asthma Proc. 2022;43(6):e65–e71.
Buyuk Yaytokgil S, Metbulut AP, Ginis T, Toyran M, Civelek E, Dibek Misirlioglu E. Cat allergy in children and the effect of the COVID-19 pandemic. Allergy Asthma Proc. 2022;43(5):e31–e9.
Hemmer W, Sestak-Greinecker G, Braunsteiner T, Wantke F, Wohrl S. Molecular sensitization patterns in animal allergy: Relationship with clinical relevance and pet ownership. Allergy. 2021;76(12):3687–96.
Trikamjee T, Basera W, Botha M, Facey-Thomas HE, Gaunt B, Genuneit J, et al. Associations between environmental dust composition and atopic dermatitis in urban and rural settings. Pediatr Allergy Immunol. 2021;32(5):1013–21.
Custovic A, de Moira AP, Murray CS, Simpson A. Environmental influences on childhood asthma: allergens. Pediatr Allergy Immunol. 2023;34(2):e13915.
Simpson A, Brough HA, Haider S, Belgrave D, Murray CS, Custovic A. Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence. J Allergy Clin Immunol. 2020;145(3):993–1001.
Stokholm J, Chawes BL, Vissing N, Bonnelykke K, Bisgaard H. Cat exposure in early life decreases asthma risk from the 17q21 high-risk variant. J Allergy Clin Immunol. 2018;141(5):1598–606.
Oksel C, Granell R, Haider S, Fontanella S, Simpson A, Turner S, et al. Distinguishing wheezing phenotypes from infancy to adolescence. A pooled analysis of five birth cohorts. Ann Am Thorac Soc. 2019;16(7):868–76.
Kopp MV, Muche-Borowski C, Abou-Dakn M, Ahrens B, Beyer K, Blumchen K, et al. S3 guideline Allergy Prevention. Allergol Sel. 2022;6:61–97.
Pinot De Moira A, Pearce N, Pedersen M, Nybo Andersen AM. The influence of early-life animal exposure on the risk of childhood atopic dermatitis, asthma and allergic rhinoconjunctivitis: findings from the Danish National Birth Cohort. Int J Epidemiol 2023;00:1-12.
Okabe H, Hashimoto K, Yamada M, Ono T, Yaginuma K, Kume Y, et al. Associations between fetal or infancy pet exposure and food allergies: the Japan Environment and Children’s Study. PLoS ONE. 2023;18(3):e282725.
Choi YJ, Seong S, Lee KS, Lee K, Seo H, Oh JW. Effects of mechanical washing and drying on the removal of pet allergens. Allergy Asthma Proc. 2022;43(5):e25–e30.
Gherasim A, de Blay F. Does air filtration work for cat allergen exposure? Curr Allergy Asthma Rep. 2020;20(6):18.
Gherasim A, Jacob A, Schoettel F, Domis N, de Blay F. Efficacy of air cleaners in asthmatics allergic to cat in ALYATEC((R)) environmental exposure chamber. Clin Exp Allergy. 2020;50(2):160–9.
Dance A. The race to deliver the hypoallergenic cat. Nature. 2020;588(7836):S7–S9.
Buckley RM, Gandolfi B, Creighton EK, Pyne CA, Bouhan DM, LeRoy ML, et al. Werewolf, there Wolf: variants in hairless associated with hypotrichia and Roaning in the Lykoi cat breed. Genes. 2020 Jun;11(6):682.
Thoms F, Haas S, Erhart A, Nett CS, Rufenacht S, Graf N, et al. Immunization of cats against Fel d 1 results in reduced allergic symptoms of owners. Viruses. 2020 Mar;12(3):288.
Dhami S, Agarwal A. Does evidence support the use of cat allergen immunotherapy? Curr Opin Allergy Clin Immunol. 2018;18(4):350–5.
Uriarte SA, Sastre J. Subcutaneous immunotherapy with high-dose cat and dog extracts: a real-life study. J Investig Allergol Clin Immunol. 2020;30(3):169–74.
Sani S, Gupta R, Fonacier L, Aquino M. Risk stratification of systemic reactions to subcutaneous immunotherapy: a retrospective study. Allergy Asthma Proc. 2019;40(5):338–42.
Alvarez-Cuesta E, Berges-Gimeno P, Gonzalez-Mancebo E, Fernandez-Caldas E, Cuesta-Herranz J, Casanovas M. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study. Allergy. 2007;62(7):810–7.
Gonzalez JPS, Hernandez EB, Abellan AC, Penalver-Mellado M. Immunogenicity of a new allergoid from Felis domesticus. Allergol Immunopathol. 2020;48(6):612–8.
Jacquet A. Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021;21(6):569–75.
Leonard C, Montamat G, Davril C, Domingues O, Hunewald O, Revets D, et al. Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1‑specific immunotherapy using high-dose CpG adjuvant. Allergy. 2021;76(7):2153–65.
Park HJ, Kim SH, Shin YS, Park CH, Cho ES, Choi SJ, et al. Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial. Respir Res. 2021;22(1):170.
Bianchini R, Roth-Walter F, Ohradanova-Repic A, Flicker S, Hufnagl K, Fischer MB, et al. IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance. Allergy. 2019;74(3):483–94.
Kamal MA, Dingman R, Wang CQ, Lai CH, Rajadhyaksha M, DeVeaux M, et al. REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamics. Clin Transl Sci. 2021;14(6):2440–9.
Shamji MH, Singh I, Layhadi JA, Ito C, Karamani A, Kouser L, et al. Passive prophylactic administration with a single dose of anti-Fel d 1 monoclonal antibodies REGN1908-1909 in cat allergen-induced allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2021;204(1):23–33.
de Blay FJ, Gherasim A, Domis N, Meier P, Shawki F, Wang CQ, et al. REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit. J Allergy Clin Immunol. 2022;150(6):1437–46.
Baloh CH, Mathias RA. Recent progress in the genetic and epigenetic underpinnings of atopy. J Allergy Clin Immunol. 2023;151(1):60–9.
Buchholz V, Bridgman SL, Nielsen CC, Gascon M, Tun HM, Simons E, et al. Natural green spaces, sensitization to allergens, and the role of gut microbiota during infancy. mSystems. 2023;8(2):e119022.
Peroni DG, Hufnagl K, Comberiati P, Roth-Walter F. Lack of iron, zinc, and vitamins as a contributor to the etiology of atopic diseases. Front Nutr. 2022;9:1032481.
Drury KE, Schaeffer M, Silverberg JI. Association between atopic disease and anemia in US children. JAMA Pediatr. 2016;170(1):29–34.
Rhew K, Brown JD, Oh JM. Atopic disease and anemia in Korean patients: cross-sectional study with propensity score analysis. Int J Environ Res Public Health. 2020 Mar 18;17(6):1978.
Rhew K, Oh JM. Association between atopic disease and anemia in pediatrics: a cross-sectional study. BMC Pediatr. 2019;19(1):455.
Roth-Walter F. Iron-deficiency in atopic diseases: innate immune priming by allergens and siderophores. Front Allergy. 2022;3:859922.
Hastka J, Metzgeroth G, Gattermann N. Eisenmangel und Eisenmangelanämie, Leitlinie der DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e. V.). onkopedia Juli 2022
Petje LM, Jensen SA, Szikora S, Sulzbacher M, Bartosik T, Pjevac P, et al. Functional iron-deficiency in women with allergic rhinitis is associated with symptoms after nasal provocation and lack of iron-sequestering microbes. Allergy. 2021;76(9):2882–6.
Yang L, Sato M, Saito-Abe M, Miyaji Y, Shimada M, Sato C, et al. Allergic disorders and risk of anemia in Japanese children: findings from the Japan environment and children’s study. Nutrients. 2022 Oct 17;14(20):4333.
Roth-Walter F, Afify SM, Pacios LF, Blokhuis BR, Redegeld F, Regner A, et al. Cow’s milk protein beta-lactoglobulin confers resilience against allergy by targeting complexed iron into immune cells. J Allergy Clin Immunol. 2021;147(1):321–334e4.
Pali-Scholl I, Bianchini R, Afify SM, Hofstetter G, Winkler S, Ahlers S, et al. Secretory protein beta-lactoglobulin in cattle stable dust may contribute to the allergy-protective farm effect. Clin Transl Allergy. 2022;12(2):e12125.
Bergmann K, Graessel A, Raab J, Banghard W, Krause L, Becker S, et al. Targeted micronutrition via holo-BLG based on the farm effect in house dust mite allergic rhinoconjunctivitis patients—first evaluation in a standardized allergen exposure chamber. Allergo J Int. 2021;30:141–9.
Funding
The article was kindly supported by Biomedical International R + D GmbH, Vienna, Austria, and by the Danube Allergy Research Cluster (DARC) project #08, Karl Landsteiner University Krems, Austria.
Funding
Open access funding provided by Medical University of Vienna.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
E. Jensen-Jarolim is a shareholder in Biomedical International R + D GmbH, Vienna, and co-inventor on patent EP 2894478 A1 “Method and means for diagnosing and treating allergy” of Biomedical Int. R + D GmbH. She is a consultant for Bencard Allergie GmbH and Allergy Therapeutics Ltd. and receives lecture fees from Bencard Allergie GmbH, Sanofi, Germania Pharmaceutics, Meda, Menarini, Novartis, Santen, Sanofi. S.A. Jensen and K.-C. Bergmann declare no conflict of interest with the content of the publication. K.-C. Bergmann is a member of advisory boards for, and receives speaking fees from GSK, AstraZeneca, Novartis, Sanofi, LETI.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jensen-Jarolim, E., Jensen, S.A. & Bergmann, KC. Allergy to the cat—from diagnosis to management. Allergo J Int 32, 130–137 (2023). https://doi.org/10.1007/s40629-023-00254-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40629-023-00254-9